1
|
Candelli M, Sacco Fernandez M, Triunfo C, Piccioni A, Ojetti V, Franceschi F, Pignataro G. Vibrio vulnificus-A Review with a Special Focus on Sepsis. Microorganisms 2025; 13:128. [PMID: 39858896 PMCID: PMC11768060 DOI: 10.3390/microorganisms13010128] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2024] [Revised: 12/28/2024] [Accepted: 01/08/2025] [Indexed: 01/27/2025] Open
Abstract
Vibrio vulnificus (V. vulnificus) is a Gram-negative, halophilic bacillus known for causing severe infections such as gastroenteritis, necrotizing fasciitis, and septic shock, with mortality rates exceeding 50% in high-risk individuals. Transmission occurs primarily through the consumption of contaminated seafood, exposure of open wounds to infected water, or, in rare cases, insect bites. The bacterium thrives in warm, brackish waters with high salinity levels, and its prevalence is rising due to the effects of climate change, including warming ocean temperatures and expanding coastal habitats. High-risk populations include individuals with underlying conditions such as chronic liver disease, diabetes, or immunosuppression, which heighten susceptibility to severe outcomes. The pathogenicity of V. vulnificus is mediated by an array of virulence factors, including hemolysins, proteases, and capsular polysaccharides, as well as mechanisms facilitating iron acquisition and immune system evasion. Clinical manifestations range from localized gastrointestinal symptoms to life-threatening systemic infections such as septicemia. Rare but severe complications, including pneumonia and meningitis, have also been reported. Treatment typically involves the use of doxycycline in combination with third-generation cephalosporins, although the emergence of multidrug-resistant strains is an escalating concern. Alternative therapeutic approaches under investigation include natural compounds such as resveratrol and the application of antimicrobial blue light. For necrotizing infections, prompt and aggressive surgical intervention remains essential to improving patient outcomes. As global temperatures continue to rise, understanding the epidemiology of V. vulnificus and developing innovative therapeutic strategies are critical to mitigating its growing public health impact.
Collapse
Affiliation(s)
- Marcello Candelli
- Emergency, Anesthesiological and Reanimation Sciences Department, Fondazione Policlinico Universitario A. Gemelli—IRCCS of Rome, 00168 Rome, Italy; (M.C.); (M.S.F.); (C.T.); (A.P.); (F.F.)
| | - Marta Sacco Fernandez
- Emergency, Anesthesiological and Reanimation Sciences Department, Fondazione Policlinico Universitario A. Gemelli—IRCCS of Rome, 00168 Rome, Italy; (M.C.); (M.S.F.); (C.T.); (A.P.); (F.F.)
| | - Cristina Triunfo
- Emergency, Anesthesiological and Reanimation Sciences Department, Fondazione Policlinico Universitario A. Gemelli—IRCCS of Rome, 00168 Rome, Italy; (M.C.); (M.S.F.); (C.T.); (A.P.); (F.F.)
| | - Andrea Piccioni
- Emergency, Anesthesiological and Reanimation Sciences Department, Fondazione Policlinico Universitario A. Gemelli—IRCCS of Rome, 00168 Rome, Italy; (M.C.); (M.S.F.); (C.T.); (A.P.); (F.F.)
| | - Veronica Ojetti
- Department of Internal Medicine, UniCamillus International Medical University of Rome, 00131 Rome, Italy;
| | - Francesco Franceschi
- Emergency, Anesthesiological and Reanimation Sciences Department, Fondazione Policlinico Universitario A. Gemelli—IRCCS of Rome, 00168 Rome, Italy; (M.C.); (M.S.F.); (C.T.); (A.P.); (F.F.)
| | - Giulia Pignataro
- Emergency, Anesthesiological and Reanimation Sciences Department, Fondazione Policlinico Universitario A. Gemelli—IRCCS of Rome, 00168 Rome, Italy; (M.C.); (M.S.F.); (C.T.); (A.P.); (F.F.)
| |
Collapse
|
2
|
Yamazaki K, Kashimoto T, Kado T, Yoshioka K, Ueno S. Increased Vascular Permeability Due to Spread and Invasion of Vibrio vulnificus in the Wound Infection Exacerbates Potentially Fatal Necrotizing Disease. Front Microbiol 2022; 13:849600. [PMID: 35350614 PMCID: PMC8957983 DOI: 10.3389/fmicb.2022.849600] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2022] [Accepted: 02/17/2022] [Indexed: 11/25/2022] Open
Abstract
Vibrio vulnificus is known to cause necrotizing soft tissue infections (NSTIs). However, the pathogenic mechanism causing cellulitis, necrotizing fasciitis, muscle necrosis, and rapidly developing septicemia in humans have not been fully elucidated. Here, we report a multilayer analysis of tissue damage after subcutaneous bacterial inoculation as a murine model of V. vulnificus NSTIs. Our histopathological examination showed the progression of cellulitis, necrotizing fasciitis, and muscle necrosis worsening as the infection penetrated deeper into the muscle tissue layers. The increase in vascular permeability was the primary cause of the swelling and congestion, which are acute signs of inflammation in soft tissue and characteristic of human NSTIs. Most importantly, our sequential analysis revealed for the first time that V. vulnificus not only spreads along the skin and subcutaneous tissues or fascia but also invades deeper muscle tissues beyond the fascia as the crucial process of its lethality. Also, increased vascular permeability enabled V. vulnificus to proliferate in muscle tissue and enter the systemic circulation, escalating the bacterium’s lethality. Our finding may yield important clinical benefits to patients by helping physicians understand the impact of surgical debridement on the patient’s quality of life. Furthermore, this study provides a promising system to accelerate studies of virulence factors and eventually help establish new therapies.
Collapse
Affiliation(s)
- Kohei Yamazaki
- Laboratory of Veterinary Public Health, School of Veterinary Medicine, Kitasato University, Towada, Japan
| | - Takashige Kashimoto
- Laboratory of Veterinary Public Health, School of Veterinary Medicine, Kitasato University, Towada, Japan
| | - Takehiro Kado
- Laboratory of Veterinary Public Health, School of Veterinary Medicine, Kitasato University, Towada, Japan.,Department of Microbiology, University of Massachusetts, Amherst, MA, United States
| | - Kazuki Yoshioka
- Laboratory of Veterinary Anatomy, School of Veterinary Medicine, Kitasato University, Towada, Japan
| | - Shunji Ueno
- Laboratory of Veterinary Public Health, School of Veterinary Medicine, Kitasato University, Towada, Japan
| |
Collapse
|
3
|
Prince JP, Bolla JR, Fisher GLM, Mäkelä J, Fournier M, Robinson CV, Arciszewska LK, Sherratt DJ. Acyl carrier protein promotes MukBEF action in Escherichia coli chromosome organization-segregation. Nat Commun 2021; 12:6721. [PMID: 34795302 PMCID: PMC8602292 DOI: 10.1038/s41467-021-27107-9] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2021] [Accepted: 11/02/2021] [Indexed: 11/22/2022] Open
Abstract
Structural Maintenance of Chromosomes (SMC) complexes act ubiquitously to compact DNA linearly, thereby facilitating chromosome organization-segregation. SMC proteins have a conserved architecture, with a dimerization hinge and an ATPase head domain separated by a long antiparallel intramolecular coiled-coil. Dimeric SMC proteins interact with essential accessory proteins, kleisins that bridge the two subunits of an SMC dimer, and HAWK/KITE proteins that interact with kleisins. The ATPase activity of the Escherichia coli SMC protein, MukB, which is essential for its in vivo function, requires its interaction with the dimeric kleisin, MukF that in turn interacts with the KITE protein, MukE. Here we demonstrate that, in addition, MukB interacts specifically with Acyl Carrier Protein (AcpP) that has essential functions in fatty acid synthesis. We characterize the AcpP interaction at the joint of the MukB coiled-coil and show that the interaction is necessary for MukB ATPase and for MukBEF function in vivo.
Collapse
Affiliation(s)
- Josh P. Prince
- grid.4991.50000 0004 1936 8948Department of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU UK ,grid.14105.310000000122478951Present Address: Meiosis Group, Medical Research Council London Institute of Medical Sciences, Du Cane Road, London, W12 0NN UK
| | - Jani R. Bolla
- grid.4991.50000 0004 1936 8948Physical and Theoretical Chemistry Laboratory, University of Oxford, South Parks Road, Oxford, OX1 3QZ UK ,The Kavli Institute for Nanoscience Discovery, South Parks Road, Oxford, OX1 3QU UK ,grid.4991.50000 0004 1936 8948Present Address: Department of Plant Sciences, University of Oxford, South Parks Road, Oxford, OX1 3QU UK
| | - Gemma L. M. Fisher
- grid.4991.50000 0004 1936 8948Department of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU UK ,grid.14105.310000000122478951Present Address: DNA Motors Group, Medical Research Council London Institute of Medical Sciences, Du Cane Road, London, W12 0NN UK
| | - Jarno Mäkelä
- grid.4991.50000 0004 1936 8948Department of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU UK ,grid.168010.e0000000419368956Present Address: ChEM-H Institute, Stanford University, 290 Jane Stanford Way, Stanford, CA 94305 USA
| | - Marjorie Fournier
- grid.4991.50000 0004 1936 8948Department of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU UK
| | - Carol V. Robinson
- grid.4991.50000 0004 1936 8948Physical and Theoretical Chemistry Laboratory, University of Oxford, South Parks Road, Oxford, OX1 3QZ UK ,The Kavli Institute for Nanoscience Discovery, South Parks Road, Oxford, OX1 3QU UK
| | - Lidia K. Arciszewska
- grid.4991.50000 0004 1936 8948Department of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU UK
| | - David J. Sherratt
- grid.4991.50000 0004 1936 8948Department of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU UK
| |
Collapse
|